The new drug called KNX100 is designed as an alternative to antipsychotic medications.
Share this @internewscast.com

An Australian-developed drug to ease the debilitating symptoms of dementia is being trialled in several states throughout the country.

Dementia often leads to changes in behavior and psychological health, affecting most patients throughout their illness. These changes can cause significant distress and add stress to families and caregivers.

“We typically associate dementia with memory loss, but the shifts in personality and behavior, such as agitation and aggression, are much more challenging and frustrating to manage,” explained Associate Professor Michael Woodward, the Director of the Austin Health Aged Care and Memory Clinic.

The new drug called KNX100 is designed as an alternative to antipsychotic medications.
The new drug called KNX100 is designed as an alternative to antipsychotic medications. (9News)

A new medication named KNX100 has been developed as an alternative to antipsychotic drugs. These antipsychotics often come with serious side effects and are used only when non-drug treatments are unsuccessful.

“It’s important that we’re able to develop new treatments that are targeted and that don’t have the side-effects particularly drowsiness that we encounter,” Trial Principal Investigator Dr Peter de Wet said .

“We need smart medications that don’t just sedate a person, don’t just chemically restrain them,” Associate Professor Woodward said.

A total of 60 dementia patients who are living at home are being recruited to participate in trials across Queensland, New South Wales, Victoria and South Australia.

The drug has already been shown in earlier trials to be safe and tolerable.

“It interferes with an enzyme (in the brain) that we know is associated with the signalling pathway that leads to agitation, aggression and other symptoms that are distressing to patients with dementia,” he said.

The innovation originated from research at the University of Sydney which led to spin out company Kinoxis.

“We’re providing a solution that we believe is a significant unmet need,”

“We aim to further develop and invest in this to take it as far as possible towards approval,” said Hugh Alsop, Kinoxis Therapeutics CEO.

Patients in Victoria, New South Wales and South Australia can find out more on the study’s website.
Share this @internewscast.com
You May Also Like
CCTV of a man who allegedly assaulted a woman and young child.

Surveillance Footage Captures Bold Attack on Woman and Child

A predator has been captured on video brazenly attacking a woman and…
Multiple cars hit during high-speed police chase across Melbourne freeways

Several Vehicles Struck in High-Speed Police Pursuit on Melbourne Highways

Authorities have apprehended a suspect accused of seizing a van and initiating…
Grok

Elon Musk’s AI chatbot unexpectedly shares antisemitic content

Grok, the AI-powered chatbot created by Elon Musk’s xAI, has begun pushing…
Man charged over alleged $20 million cocaine plot

Man Accused in Alleged $20 Million Cocaine Scheme

A man is set to appear in court later this year, following…

Exploring Australia’s Proposed Plan Against Antisemitism

Jillian Segal, Australia’s envoy on antisemitism, has put forth a strategy to…
President Donald Trump speaks during a cabinet meeting

Trump Announces Plans to Make a ‘Significant’ Statement on Russia

Two days after complaining about Vladimir Putin’s “bulls—“, Donald Trump says he’s…

Melbourne’s Oldest Bookshop Gets a New Home with Help from Hundreds

Book by book, hand to hand — hundreds formed a human chain…
A car crash in Adelaide.

Motorist in fatal accident that claimed a mother’s life escapes life imprisonment

An Adelaide woman lost her life in a tragic accident with an…

“Brazil’s President Threatens Equivalent Retaliation to Trump’s Tariff Plan, Vows ‘We’ll Impose a 50% Charge'”

Brazil’s President Luiz Inacio Lula da Silva expressed his desire for a…
Sabrina wanted to make some extra cash but ended up broke.

Sabrina Tried a Popular Side Hustle for Extra Cash, But It Ended Badly

Exclusive: Sabrina wanted to make some extra cash. Chloe* followed other local…
Surfer Steven Payne (pictured, with his dog Poppy) had been travelling Western Australia with his partner Catherine Birch when he was fatally attacked by a great white, an inquest has heard

New Information Surfaces After 37-Year-Old Surfer Is Fatally Attacked by Shark in Front of His Girlfriend at Australian Beach

A surfer, tragically killed by a great white shark at a Western…
Second Australian city becomes million-dollar housing market

Another Major Australian City Enters the Million-Dollar Housing Club

Brisbane is now part of Australia’s million-dollar property markets, with median house…